Skip to main content
. Author manuscript; available in PMC: 2014 Jun 30.
Published in final edited form as: J Bone Miner Res. 2013 Apr;28(4):865–874. doi: 10.1002/jbmr.1807

Fig. 4.

Fig. 4

Effect of unloading and sclerostin treatment on femoral strength as assessed by three-point bending, (A) maximum force, and (B) bending stiffness. Horizontal bars designate significant differences between VEH and SclAbII within loading group (p < 0.01); †p < 0.01 CON versus HLU within a treatment group.